Alpine Immune Sciences

$7.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.87%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ALPN and other stocks, options, and ETFs commission-free!

About ALPN

Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company. Read More The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA. The listed name for ALPN is Alpine Immune Sciences, Inc. Common Stock.

Employees
53
Headquarters
Seattle, Washington
Founded
2015
Market Cap
188.85M
Price-Earnings Ratio
Dividend Yield
Average Volume
38.85K
High Today
$8.20
Low Today
$7.97
Open Price
$8.13
Volume
11.19K
52 Week High
$15.00
52 Week Low
$2.05

Collections

ALPN Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 11, After Hours

You May Also Like